By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Intercept Pharmaceuticals 

450 W 15th Street
Suite 505
New York City  New York  10011  U.S.A.
Phone: 646-747-1000 Fax: 646-747-1001



Company News
The M&A Rumor Mill Points to Gilead (GILD) Acquiring Intercept Pharma (ICPT) 4/25/2016 6:44:14 AM
FDA Panel Unanimously Backs Speedy Approval of Intercept Pharma (ICPT)'s Liver Disease Drug Ocaliva 4/8/2016 6:06:38 AM
Adam Feuerstein's Biotech Stock Mailbag: Intercept Pharma (ICPT), Acadia (ACAD), Keryx (KERX). Galena Biopharma  (GALE) 4/1/2016 7:46:32 AM
Three Biotechs Cited as Promising Bets in 2016 With FDA Decisions Pending 2/15/2016 6:28:46 AM
AstraZeneca PLC (AZN) Rumored to Be Interested in Buying Intercept Pharma (ICPT) 2/11/2016 6:17:10 AM
Gino Santini And Daniel Welch Elected To Board Of Directors Of Intercept Pharma (ICPT) 12/11/2015 7:31:03 AM
Intercept Pharma (ICPT) Announces Initiation Of Prospective Trial To Explore Effect Of Combined OCA And Statin Therapy On Lipid Metabolism In NASH Patients 12/7/2015 7:48:05 AM
Intercept Pharma (ICPT) To Present At The Oppenheimer Healthcare Conference 12/3/2015 8:42:44 AM
Intercept Pharma (ICPT) Initiates Phase I Study Of INT-767, A Dual FXR And TGR5 Agonist 12/1/2015 7:18:09 AM
Intercept Pharma (ICPT) Presents New PBC Data At American Association for Study of Liver Diseases 2015 11/16/2015 8:30:56 AM